Review: taking Metoprolol succinate and Aleve together


Summary

Drug interactions are reported among people who take Metoprolol succinate and Aleve together. This review analyzes the effectiveness and drug interactions between Metoprolol succinate and Aleve. It is created by eHealthMe based on reports of 1,237 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Metoprolol succinate and Aleve >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Metoprolol Succinate

Metoprolol succinate has active ingredients of metoprolol succinate. It is often used in high blood pressure. (latest outcomes from Metoprolol succinate 18,440 users)

Aleve

Aleve has active ingredients of naproxen sodium. It is often used in arthritis. (latest outcomes from Aleve 23,811 users)

On Aug, 20, 2016

1,237 people who take Metoprolol Succinate, Aleve are studied.


Number of reports submitted per year:

Metoprolol succinate and Aleve drug interactions.

Drug effectiveness over time:

Metoprolol Succinate:
  • < 1 month: 50.0% - (1 of 2 people)
  • 1 - 6 months: 25.0% - (1 of 4 people)
  • 6 - 12 months: 100.0% - (1 of 1 people)
  • 1 - 2 years: 100.0% - (3 of 3 people)
  • 2 - 5 years: 50.0% - (2 of 4 people)
  • 5 - 10 years: 60.0% - (3 of 5 people)
  • 10+ years: 75.0% - (3 of 4 people)
  • not specified: 0.0% - (0 of 0 people)
Aleve:
  • < 1 month: 28.0% - (2 of 7 people)
  • 1 - 6 months: 25.0% - (1 of 4 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 1 people)
  • 2 - 5 years: 16.0% - (1 of 6 people)
  • 5 - 10 years: 50.0% - (1 of 2 people)
  • 10+ years: 100.0% - (1 of 1 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Metoprolol Succinate:
  • female: 71.0% - (10 of 14 people)
  • male: 44.0% - (4 of 9 people)
Aleve:
  • female: 30.0% - (4 of 13 people)
  • male: 25.0% - (2 of 8 people)

Drug effectiveness by age:

Metoprolol Succinate:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 1 people)
  • 40-49: 100.0% - (2 of 2 people)
  • 50-59: 77.0% - (7 of 9 people)
  • 60+: 45.0% - (5 of 11 people)
Aleve:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 1 people)
  • 40-49: 100.0% - (1 of 1 people)
  • 50-59: 12.0% - (1 of 8 people)
  • 60+: 36.0% - (4 of 11 people)

Most common drug interactions over time *:

< 1 month:
  • blood pressure increased
  • dizziness
  • nausea
  • renal failure acute
  • acute respiratory failure
  • anaemia
  • chest pain
  • fatigue
  • hypersensitivity
  • overdose
1 - 6 months:
  • oedema peripheral
  • acute myocardial infarction
  • arthralgia
  • burning sensation
  • chest pain
  • drug ineffective
  • joint swelling
  • pain in extremity
  • abdominal pain upper
  • angina unstable
6 - 12 months:
  • nausea
  • blood calcium increased
  • dysphagia
  • dysphonia
  • dyspnoea
  • speech disorder
  • therapeutic response decreased
  • thyroid neoplasm
  • vocal cord paralysis
  • weight decreased
1 - 2 years:
  • dyspnoea
  • blood calcium increased
  • dysphagia
  • dysphonia
  • nausea
  • speech disorder
  • therapeutic response decreased
  • thyroid neoplasm
  • vocal cord paralysis
  • weight decreased
2 - 5 years:
  • pulmonary embolism
  • deep vein thrombosis
  • headache
  • mental disorder
  • oedema peripheral
  • pain in extremity
  • acute myocardial infarction
  • anxiety
  • asthma
  • atrial fibrillation
5 - 10 years:
  • loss of consciousness
  • abnormal behaviour
  • aggression
  • anger
  • anxiety
  • back pain
  • blood in stool
  • cardiac disorder
  • circadian rhythm sleep disorder
  • death
10+ years:
  • asthma
  • atrial fibrillation
  • blood glucose
  • edema - peripheral, peripheral edema
  • breast cancer in situ
  • chest pain
  • dizziness
  • dyspepsia
  • fatigue
  • foot swelling
not specified:
  • nausea
  • dyspnoea
  • pain
  • anxiety
  • fatigue
  • injury
  • dizziness
  • vomiting
  • arthralgia
  • diarrhoea

Most common drug interactions by gender *:

female:
  • nausea
  • pain
  • dyspnoea
  • anxiety
  • hypertension
  • pain in extremity
  • diarrhoea
  • fatigue
  • dizziness
  • insomnia
male:
  • dyspnoea
  • nausea
  • pain
  • anxiety
  • injury
  • dizziness
  • fatigue
  • atrial fibrillation
  • myocardial infarction
  • arthralgia

Most common drug interactions by age *:

0-1:
  • arthritis
  • blood cholesterol increased
  • cerebrovascular accident
  • convulsion
  • diabetic neuropathy
  • dyspnoea
  • enzyme abnormality
  • haematochezia
  • hypercalcaemia
  • hyperlipidaemia
10-19:
  • cholecystitis chronic
  • myocardial infarction
  • gallbladder cholesterolosis
  • oesophagitis
  • abdominal pain
  • back pain
  • bradycardia
  • cerebrovascular accident
  • cholelithiasis
  • chronic obstructive pulmonary disease
20-29:
  • cardiac failure congestive
  • nausea
  • back pain
  • bronchitis
  • cholecystitis
  • cholelithiasis
  • dyspnoea
  • influenza like illness
  • insomnia
  • presyncope
30-39:
  • dyspnoea
  • abdominal pain upper
  • anxiety
  • pain in extremity
  • cough
  • depression
  • injury
  • pain
  • back pain
  • bronchitis
40-49:
  • pain
  • myocardial infarction
  • depression
  • diabetes mellitus
  • arthralgia
  • dizziness
  • anxiety
  • hypertension
  • nausea
  • diarrhoea
50-59:
  • nausea
  • dyspnoea
  • diarrhoea
  • dysphagia
  • chest pain
  • dizziness
  • vomiting
  • abdominal pain
  • pain
  • pain in extremity
60+:
  • nausea
  • dyspnoea
  • fatigue
  • pain
  • anxiety
  • dizziness
  • diarrhoea
  • vomiting
  • anaemia
  • asthenia

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Metoprolol succinate and Aleve?

Can you answer these questions?

More questions for: Metoprolol succinate, Aleve

You may be interested in these reviews

More reviews for: Metoprolol succinate, Aleve

On eHealthMe, Metoprolol succinate (metoprolol succinate) is often used to treat high blood pressure. Aleve (naproxen sodium) is often used to treat arthritis. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.